Monitoring antiretroviral therapy in HIV-infected children in resource-limited countries: A tale of two epidemics

AIDS Research and Treatment

Volumn 2011, Issue , 2011, Pages

  Paintsil, Elijah ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84863985503     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2011/280901     Document Type: Review

References (82)

1. Paintsil E., Andiman W. A., Update on successes and challenges regarding mother-to-child transmission of HIV. Current Opinion in Pediatrics 2009 21 1 94 101 2-s2.0-62849107032 10.1097/MOP.0b013e32831ec353
2. Connor E. M., Sperling R. S., Gelber R., Kiselev P., Scott G., O'Sullivan M. J., Vandyke R., Bey M., Shearer W., Jacobson R. L., Jimenez E., O'Neill E., Bazin B., Delfraissy J. -F., Culnane M., Coombs R., Elkins M., Moye J., Stratton P., Balsley J., Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New England Journal of Medicine 1994 331 18 1173 1180 10.1056/NEJM199411033311801 (Pubitemid 24331334)
3. Yeni P. G., Hammer S. M., Hirsch M. S., Saag M. S., Schechter M., Carpenter C. C. J., Fischl M. A., Gatell J. M., Gazzard B. G., Jacobsen D. M., Katzenstein D. A., Montaner J. S. G., Richman D. D., Schooley R. T., Thompson M. A., Vella S., Volberding P. A., Treatment for adult HIV infection: 2004 recommendations of the international AIDS society-USA panel. Journal of the American Medical Association 2004 292 2 251 265 2-s2.0-3042726798 10.1001/jama.292.2.251 (Pubitemid 38918003)
4. Report on the global AIDS epidemic; executive summary. Joint United Nations Programme on HIV/AIDS, 2008
5. Ginsburg A. S., Hoblitzelle C. W., Sripipatana T. L., Wilfert C. M., Provision of care following prevention of mother-to-child HIV transmission services in resource-limited settings. AIDS 2007 21 18 2529 2532 2-s2.0-36349017175 10.1097/QAD.0b013e3282f155f4 (Pubitemid 350145185)
6. Creek T., Tgc0@cdc.gov Ntumy R., Mazhani L., Moore J., Smith M., Han G., Shaffer N., Kilmarx P. H., Factors associated with low early uptake of a national program to prevent mother to child transmission of HIV (PMTCT): results of a survey of mothers and providers, Botswana, 2003. AIDS and Behavior 2009 13 2 356 364 10.1007/s10461-007-9322-8
7. Nkonki L. L., Doherty T. M., Hill Z., Chopra M., Schaay N., Kendall C., Missed opportunities for participation in prevention of mother to child transmission programmes: simplicity of nevirapine does not necessarily lead to optimal uptake, a qualitative study. AIDS Research and Therapy 2007 4 2-s2.0-38549123961 10.1186/1742-6405-4-27 27 (Pubitemid 351149920)
8. Vlahov D., Graham N., Hoover D., Flynn C., Bartlett J. G., Margolick J. B., Lyles C. M., Nelson K. E., Smith D., Holmberg S., Farzadegan H., Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. Journal of the American Medical Association 1998 279 1 35 40 2-s2.0-0010240431 10.1001/jama.279.1.35 (Pubitemid 28070548)
9. Nishanian P., Taylor J. M. G., Manna B., Aziz N., Grosser S., Giorgi J. V., Detels R., Fahey J. L., Accelerated changes (inflection points) in levels of serum immune activation markers and CD4+ and CD8+ T cells prior to AIDS onset. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998 18 2 162 170 2-s2.0-0032104043
10. Pantaleo G., Graziosi C., Fauci A. S., The immunopathogenesis of human immunodeficiency virus infection. New England Journal of Medicine 1993 328 5 327 335 2-s2.0-0027908330 10.1056/NEJM199302043280508 (Pubitemid 23035333)
11. Gortmaker S. L., Hughes M., Cervia J., Brady M., Johnson G. M., Seage G. R. III, Song L. Y., Dankner W. M., Oleske J. M., Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. New England Journal of Medicine 2001 345 21 1522 1528 2-s2.0-0035936007 10.1056/NEJMoa011157 (Pubitemid 33144917)
12. Gibb D. M., Duong T., Tookey P. A., Sharland M., Tudor-Williams G., Novelli V., Butler K., Riordan A., Farrelly L., Masters J., Peckham C. S., Dunn D. T., Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland. British Medical Journal 2003 327 7422 1019 1023 2-s2.0-0242288797 (Pubitemid 37357464)
13. Fassinou P., Elenga N., Rouet F., Laguide R., Kouakoussui K. A., Timite M., Blanche S., Msellati P., Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote d'Ivoire. AIDS 2004 18 14 1905 1913 2-s2.0-4744351547 10.1097/00002030-200409240-00006 (Pubitemid 39313206)
14. Puthanakit T., Aurpibul L., Oberdorfer P., Akarathum N., Kanjananit S., Wannarit P., Sirisanthana T., Sirisanthana V., Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy. Clinical Infectious Diseases 2007 44 4 599 604 2-s2.0-33846898997 10.1086/510489 (Pubitemid 46233267)
15. O'Brien D. P., Sauvageot D., Zachariah R., Humblet P., In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy. AIDS 2006 20 15 1955 1960 2-s2.0-33748898058 10.1097/01.aids.0000247117.66585.ce (Pubitemid 44427613)
16. O'Brien D. P., Sauvageot D., Olson D., Schaeffer M., Humblet P., Pudjades M., Ellman T., Zachariah R., Szumilin E., Arnould L., Read T., Treatment outcomes stratified by baseline immunological status among young children receiving nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings. Clinical Infectious Diseases 2007 44 9 1245 1248 2-s2.0-34247275856 10.1086/513433 (Pubitemid 46651252)
17. Kline M. W., Rugina S., Ilie M., Matusa R. F., Schweitzer A.-M., Calles N. R., Schwarzwald H. L., Long-term follow-up of 414 HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy. Pediatrics 2007 119 5 e1116 e1120 2-s2.0-34248191264 10.1542/peds.2006-2802 (Pubitemid 46715649)
18. Lenert L. A., Feddersen M., Sturley A., Lee D., Adverse effects of medications and trade-offs between length of life and quality of life in human immunodeficiency virus infection. American Journal of Medicine 2002 113 3 229 232 2-s2.0-0037101988 10.1016/S0002-9343(02)01156-7 (Pubitemid 35245632)
19. Powderly W. G., Long-term exposure to lifelong therapies. Journal of Acquired Immune Deficiency Syndromes 2002 29 1 S28 S40 2-s2.0-0036470917 (Pubitemid 34163470)
20. Antiretroviral therapy of HIV infection in infants and children: towards universal access. Recommendations for a public health approach-2010 revision. World Health Organization, Geneva, Switzerland, September 2010, http://www.who.int/hiv/pub/guidelines/art/index.html
21. Sutcliffe C. G., van Dijk J. H., Bolton C., Persaud D., Moss W. J., Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. The Lancet Infectious Diseases 2008 8 8 477 489 2-s2.0-47549096477 10.1016/S1473-3099(08)70180-4 (Pubitemid 352005822)
22. George E., Noël F., Bois G., Cassagnol R., Estavien L., De Rouzier P. M., Verdier R. I., Johnson W. D., Pape J. W., Fitzgerald D. W., Wright P. F., Antiretroviral therapy for HIV-1-infected children in Haiti. Journal of Infectious Diseases 2007 195 10 1411 1418 2-s2.0-34248165490 10.1086/514823 (Pubitemid 46717458)
23. Janssens B., Raleigh B., Soeung S., Akaob K., Te V., Gupta J., Vun M. C., Ford N., Nouhinf J., Nerrienet E., Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia. Pediatrics 2007 120 5 e1134 e1140 2-s2.0-36048946593 10.1542/peds.2006-3503 (Pubitemid 350085507)
24. Bolton-Moore C., Mubiana-Mbewe M., Cantrell R. A., Chintu N., Stringer E. M., Chi B. H., Sinkala M., Kankasa C., Wilson C. M., Wilfert C. M., Mwango A., Levy J., Abrams E. J., Bulterys M., Stringer J. S. A., Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. Journal of the American Medical Association 2007 298 16 1888 1899 2-s2.0-35448950466 10.1001/jama.298.16.1888 (Pubitemid 350005233)
25. Reddi A., Leeper S. C., Grobler A. C., Geddes R., France K. H., Dorse G. L., Vlok W. J., Mntambo M., Thomas M., Nixon K., Holst H. L., Karim Q. A., Rollins N. C., Coovadia H. M., Giddy J., Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatrics 2007 7 2-s2.0-34147098059 10.1186/1471-2431-7-13 13 (Pubitemid 46553973)
26. Mellors J. W., Muñoz A., Giorgi J. V., Margolick J. B., Tassoni C. J., Gupta P., Kingsley L. A., Todd J. A., Saah A. J., Detels R., Phair J. P., Rinaldo C. R. Jr., Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Annals of Internal Medicine 1997 126 12 946 954 2-s2.0-1842296349 (Pubitemid 27255797)
27. Diagbouga S., Chazallon C., Kazatchkine M. D., Van De Perre P., Inwoley A., M'Boup S., David M. P., Ténin A. T., Soudré R., Aboulker J.-P., Weiss L., Successful implementation of a low-cost method for enumerating CD4 + T lymphocytes in resource-limited settings: the ANRS 12-26 study. AIDS 2003 17 15 2201 2208 2-s2.0-10744228347 10.1097/00002030-200310170-00008 (Pubitemid 37338893)
28. Zampoli M., Kilborn T., Eley B., Tuberculosis during early antiretroviral-induced immune reconstitution in HIV-infected children. International Journal of Tuberculosis and Lung Disease 2007 11 4 417 423 2-s2.0-34247133902 (Pubitemid 46595772)
29. Nachman S. A., Lindsey J. C., Moye J., Stanley K. E., Johnson G. M., Krogstad P. A., Wiznia A. A., Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatric Infectious Disease Journal 2005 24 4 352 357 2-s2.0-17144407574 10.1097/01.inf.0000157095. 75081.43 (Pubitemid 40525344)
30. Verweel G., van Rossum A. M., Hartwig N. G., Wolfs T. F., Scherpbier H. J., de Groot R., Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Pediatrics 2002 109 2 E25 2-s2.0-0036479949
31. Blè C., Floridia M., Muhale C., Motto S., Giuliano M., Gabbuti A., Giuman L., Mazzotta F., Efficacy of highly active antiretroviral therapy in HIV-infected, institutionalized orphaned children in Tanzania. Acta Paediatrica, International Journal of Paediatrics 2007 96 7 1090 1094 2-s2.0-34250638515 10.1111/j.1651-2227.2007.00352.x (Pubitemid 46934464)
32. Marazzi M. C., Germano P., Liotta G., Buonomo E., Guidotti G., Palombi L., Pediatric highly active antiretroviral therapy in Mozambique: an integrated model of care. Minerva Pediatrica 2006 58 5 483 490 2-s2.0-33750607878 (Pubitemid 44690318)
33. Walker A. S., Mulenga V., Ford D., Kabamba D., Sinyinza F., Kankasa C., Chintu C., Gibb D. M., The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children. Clinical Infectious Diseases 2007 44 10 1361 1367 2-s2.0-34248230798 10.1086/515396 (Pubitemid 46717300)
34. Steiner F., Kind C., Aebi C., Wyler-Lazarevitch C.-A., Cheseaux J.-J., Rudin C., Molinari L., Nadal D., Growth in human immunodeficiency virus type 1-infected children treated with protease inhibitors. European Journal of Pediatrics 2001 160 10 611 616 2-s2.0-0034786786 10.1007/s004310100820 (Pubitemid 32939432)
35. Guillén S., Ramos J. T., Resino R., Bellón J. M., Muñoz M. A., Impact on weight and height with the use of HAART in HIV-infected children. Pediatric Infectious Disease Journal 2007 26 4 334 338 2-s2.0-34247121800 10.1097/01.inf.0000257427.19764.ff (Pubitemid 46596659)
36. Farmer P., Léandre F., Mukherjee J. S., Claude M. S., Nevil P., Smith-Fawzi M. C., Koenig S. P., Castro A., Becerra M. C., Sachs J., Attaran A., Kim J. Y., Community-based approaches to HIV treatment in resource-poor settings. The Lancet 2001 358 9279 404 409 2-s2.0-0035806721 10.1016/S0140-6736(01)05550-7 (Pubitemid 32739107)
37. Mekonnen Y., Dukers N. H. T. M., Sanders E., Dorigo W., Wolday D., Schaap A., Geskus R. B., Coutinho R. A., Fontanet A., Simple markers for initiating antiretroviral therapy among HIV-infected Ethiopians. AIDS 2003 17 6 815 819 2-s2.0-0038640533 10.1097/00002030-200304110-00006 (Pubitemid 36547653)
38. Patel K., Weinberg G. A., Buchacz K., McIntosh K., Dankner W. M., Seage G. R. III, Simple pediatric AIDS severity score (PASS): a pediatric severity score for resource-limited settings. Journal of Acquired Immune Deficiency Syndromes 2006 43 5 611 617 2-s2.0-33845368423 10.1097/01.qai.0000242454.97650. 72 (Pubitemid 44885630)
39. Wamalwa D. C., Farquhar C., Obimbo E. M., Selig S., Mbori-Ngacha D. A., Richardson B. A., Overbaugh J., Emery S., Wariua G., Gichuhi C., Bosire R., John-Stewart G., Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children. Journal of Acquired Immune Deficiency Syndromes 2007 45 3 311 317 2-s2.0-34347357578 10.1097/QAI.0b013e318042d613 (Pubitemid 47012378)
40. Paterson D. L., Swindells S., Mohr J., Brester M., Vergis E. N., Squier C., Wagener M. M., Singh N., Hudson B., Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine 2000 133 1 21 30 2-s2.0-0034604276 (Pubitemid 30432540)
41. Harries A. D., Gomani P., Teck R., de Teck O. A., Bakali E., Zachariah R., Libamba E., Mwansambo A., Salaniponi F., Mpazanje R., Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi model. Transactions of the Royal Society of Tropical Medicine and Hygiene 2004 98 12 695 701 2-s2.0-5144232096 10.1016/j.trstmh.2004.05.002 (Pubitemid 39345147)
42. Elise A., France A. M., Louise W. M., Bata D., François R., Roger S., Philippe M., Assessment of adherence to highly active antiretroviral therapy in a cohort of African HIV-infected children in Abidjan, Cote d'Ivoire. Journal of Acquired Immune Deficiency Syndromes 2005 40 4 498 500 2-s2.0-27944491926 10.1097/01.qai.0000168180.76405.5f (Pubitemid 41669187)
43. Nyandiko W. M., Ayaya S., Nabakwe E., Tenge C., Sidle J. E., Yiannoutsos C. T., Musick B., Wools-Kaloustian K., Tierney W. M., Outcomes of HIV-infected orphaned and non-orphaned children on antiretroviral therapy in Western Kenya. Journal of Acquired Immune Deficiency Syndromes 2006 43 4 418 425 2-s2.0-33750952719 10.1097/01.qai.0000243122.52282.89 (Pubitemid 44737098)
44. Bikaako-Kajura W., Luyirika E., Purcell D. W., Downing J., Kaharuza F., Mermin J., Malamba S., Bunnell R., Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS and Behavior 2006 10 7 S85 S93 2-s2.0-33746878840 10.1007/s10461-006-9141-3
45. Nabukeera-Barungi N., Kalyesubula I., Kekitiinwa A., Byakika-Tusiime J., Musoke P., Adherence to antiretroviral therapy in children attending Mulago Hospital, Kampala. Annals of Tropical Paediatrics 2007 27 2 123 131 2-s2.0-34547662490 10.1179/146532807X192499 (Pubitemid 47629159)
46. Wendel C. S., Mohler M. J., Kroesen K., Ampel N. M., Gifford A. L., Coons S. J., Barriers to use of electronic adherence monitoring in an HIV clinic. Annals of Pharmacotherapy 2001 35 9 1010 1015 2-s2.0-0034829731 (Pubitemid 32880016)
47. Miller L. G., Hays R. D., Measuring adherence to ant i retro viral medications in clinical trials. HIV Clinical Trials 2000 1 1 36 46 2-s2.0-0034232192
48. Bisson G. P., Gross R., Bellamy S., Chittams J., Hislop M., Regensberg L., Frank I., Maartens G., Nachega J. B., Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy. PLoS Medicine 2008 5 5 e109 2-s2.0-48849109496 10.1371/journal.pmed. 0050109 (Pubitemid 351760907)
49. Grossberg R., Zhang Y., Gross R., A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. Journal of Clinical Epidemiology 2004 57 10 1107 1110 2-s2.0-7544238028 10.1016/j.jclinepi.2004.04.002 (Pubitemid 39451804)
50. Gulick R. M., Mellors J. W., Havlir D., Eron J. J., Gonzalez C., McMahon D., Richman D. D., Valentine F. T., Jonas L., Meibohm A., Emini E. A., Chodakewitz J. A., Deutsch P., Holder D., Schleif W. A., Condra J. H., Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. New England Journal of Medicine 1997 337 11 734 739 2-s2.0-0030869269 10.1056/ NEJM199709113371102 (Pubitemid 27417972)
51. Hammer S. M., Saag M. S., Schechter M., Montaner J. S. G., Schooley R. T., Jacobsen D. M., Thompson M. A., Carpenter C. C. J., Fischl M. A., Gazzard B. G., Gatell J. M., Hirsch M. S., Katzenstein D. A., Richman D. D., Vella S., Yeni P. G., Volberding P. A., Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. Journal of the American Medical Association 2006 296 7 827 843 2-s2.0-33747122666 10.1001/jama.296.7.827 (Pubitemid 44223106)
52. O'Brien W. A., Hartigan P. M., Daar E. S., Simberkoff M. S., Hamilton J. D., Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. Annals of Internal Medicine 1997 126 12 939 945 (Pubitemid 27255796)
53. Ghaffari G., Passalacqua D. J., Caicedo J. L., Goodenow M. M., Sleasman J. W., jsleasma@hsc.usf.edu Two-year clinical and immune outcomes in human immunodeficiency virus-infected children who reconstitute CD4 T cells without control of viral replication after combination antiretroviral therapy. Pediatrics 2004 114 5 e604 e611 10.1542/peds.2004-0274 (Pubitemid 41647669)
54. Song R., Jelagat J., Dzombo D., Mwalimu M., Mandaliya K., Shikely K., Essajee S., Efficacy of highly active antiretroviral therapy in HIV-1-infected children in Kenya. Pediatrics 2007 120 4 e856 e861 2-s2.0-35148813458 10.1542/peds.2006-1122 (Pubitemid 47549528)
55. Puthanakit T., Oberdorfer A., Akarathum N., Kanjanavanit S., Wannarit P., Sirisanthana T., Sirisanthana V., Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program. Clinical Infectious Diseases 2005 41 1 100 107 2-s2.0-20844446474 10.1086/430714 (Pubitemid 40863751)
56. Puthanakit T., Kerr S. J., Ananworanich J., Bunupuradah T., Boonrak P., Sirisanthana V., Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy. Pediatric Infectious Disease Journal 2009 28 6 488 492 2-s2.0-67649559583 10.1097/INF.0b013e318194eea6
57. Kumarasamy N., Venkatesh K. K., Devaleenol B., Poongulali S., Moothi S. N., Solomon S., Safety, tolerability and effectiveness of generic HAART in HIV-infected children in South India. Journal of Tropical Pediatrics 2009 55 3 155 159 2-s2.0-67149125836 10.1093/tropej/fmn080
58. García F., De Lazzari E., Plana M., Castro P., Mestre G., Nomdedeu M., Fumero E., Martínez E., Mallolas J., Blanco J. L., Miró J. M., Pumarola T., Gallart T., Gatell J. M., Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count. Journal of Acquired Immune Deficiency Syndromes 2004 36 2 702 713 2-s2.0-2542496096 10.1097/00126334-200406010-00007 (Pubitemid 38685964)
59. Kaufmann G. R., Furrer H., Ledergerber B., Perrin L., Opravil M., Vernazza P., Cavassini M., Bernasconi E., Rickenbach M., Hirschel B., Battegay M., Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/ L in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clinical Infectious Diseases 2005 41 3 361 372 2-s2.0-22544453346 10.1086/431484 (Pubitemid 41022115)
60. Moore R. D., Keruly J. C., CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clinical Infectious Diseases 2007 44 3 441 446 2-s2.0-33846439783 10.1086/510746 (Pubitemid 46147630)
61. Kamya M. R., Mayanja-Kizza H., Kambugu A., Bakeera-Kitaka S., Semitala F., Mwebaze-Songa P., Castelnuovo B., Schaefer P., Spacek L. A., Gasasira A. F., Katabira E., Colebunders R., Quinn T. C., Ronald A., Thomas D. L., Kekitiinwa A., Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 2007 46 2 187 193 2-s2.0-34748846895 10.1097/QAI.0b013e31814278c0 (Pubitemid 47482614)
62. Rouet F., Fassinou P., Inwoley A., Anaky M.-F., Kouakoussui A., Rouzioux C., Blanche S., Msellati P., Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens. AIDS 2006 20 18 2315 2319 2-s2.0-33751221917 10.1097/QAD. 0b013e328010943b (Pubitemid 44789533)
63. Wade A. M., Ades A. E., Incorporating correlations between measurements into the estimation of age-related reference ranges. Statistics in Medicine 1998 17 17 1989 2002 2-s2.0-0031671318 10.1002/(SICI)1097-0258(19980915)17: 17<1989::AID-SIM891>3.0.CO;2-Q (Pubitemid 28425262)
64. Stein D. S., Korvick J. A., Vermund S. H., CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. Journal of Infectious Diseases 1992 165 2 352 363 2-s2.0-0026515551
65. Hughes M. D., Stein D. S., Gundacker H. M., Valentine F. T., Phair J. P., Volberding P. A., Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. Journal of Infectious Diseases 1994 169 1 28 36 2-s2.0-0027958415
66. Paintsil E., Ghebremichael M., Romano S., Andiman W. A., Absolute CD4+ T-lymphocyte count as a surrogate marker of pediatric human immunodeficiency virus disease progression. Pediatric Infectious Disease Journal 2008 27 7 629 635 2-s2.0-50949126367 10.1097/INF.0b013e3181693892
67. Dunn D., Use of total lymphocyte count for informing when to start antiretroviral therapy in HIV-infected children: a meta-analysis of longitudinal data. The Lancet 2005 366 9500 1868 1874 2-s2.0-28044466931 10.1016/S0140-6736(05)67757-4 (Pubitemid 41690115)
68. De Rossi A., Virological and immunological response to antiretroviral therapy in HIV-1 infected children: genotypic and phenotypic assays in monitoring virological failure. New Microbiologica 2004 27 2, supplement 1 45 50 2-s2.0-11844282111 (Pubitemid 40090989)
69. van Rossum A. M. C., Fraaij P. L. A., de Groot R., Efficacy of highly active antiretroviral therapy in HIV-1 infected children. Lancet Infectious Diseases 2002 2 2 93 102 2-s2.0-0036488217 10.1016/S1473-3099(02)00183-4 (Pubitemid 36114143)
70. Fraaij P. L. A., Verweel G., Van Rossum A. M. C., Van Lochem E. G., Schutten M., Weemaes C. M. R., Hartwig N. G., Burger D. M., De Groot R., Sustained viral suppression and immune recovery in HIV type 1-infected children after 4 years of highly active antiretroviral therapy. Clinical Infectious Diseases 2005 40 4 604 608 2-s2.0-13944270978 10.1086/427696 (Pubitemid 40270233)
71. Duncombe C., Kerr S. J., Ruxrungtham K., Dore G. J., Law M. G., Emery S., Lange J. M., Phanuphak P., Cooper D. A., HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting. AIDS 2005 19 2 169 178 2-s2.0-15744378534 (Pubitemid 40409535)
72. Chene G., Sterne J. A., May M., Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. The Lancet 2003 362 9385 679 686 10.1016/S0140-6736(03) 14229-8 (Pubitemid 37101064)
73. Janossy G., Mandy F., O'Gorman M. R. G., Diagnostics in the shadow of HIV epidemics. Cytometry B: Clinical Cytometry 2008 74 supplement 1 S1 S3 2-s2.0-42449144258 10.1002/cyto.b.20404 (Pubitemid 351569265)
74. Schnittman S. M., Lane H. C., Greenhouse J., Justement J. S., Baseler M., Fauci A. S., Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proceedings of the National Academy of Sciences of the United States of America 1990 87 16 6058 6062 2-s2.0-0025160079 10.1073/pnas.87.16.6058 (Pubitemid 20258955)
75. Veazey R. S., DeMaria M., Chalifoux L. V., Shvetz D. E., Pauley D. R., Knight H. L., Rosenzweig M., Johnson R. P., Desrosiers R. C., Lackner A. A., Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998 280 5362 427 431 2-s2.0-0032540418 10.1126/science.280.5362.427 (Pubitemid 28208163)
76. Pakker N. G., Notermans D. W., De Boer R. J., Roos M. T. L., De Wolf F., Hill A., Leonard J. M., Danner S. A., Miedema F., Schellekens P. T. A., Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nature Medicine 1998 4 2 208 214 2-s2.0-0031882434 10.1038/nm0298-208 (Pubitemid 28137376)
77. Mandy F., Janossy G., Bergeron M., Pilon R., Faucher S., Affordable CD4 T-cell enumeration for resource-limited regions: a status report for 2008. Cytometry B: Clinical Cytometry 2008 74 1 S27 S39 2-s2.0-42449163377 10.1002/cyto.b.20414 (Pubitemid 351569270)
78. Taiwo B. O., Murphy R. L., Clinical applications and availability of CD4+ T cell count testing in sub-Saharan Africa. Cytometry B: Clinical Cytometry 2008 74 supplement 1 S11 S18 2-s2.0-42449125184 10.1002/cyto.b.20383 (Pubitemid 351569268)
79. Katzenstein D., Laga M., Moatti J.-P., The evaluation of the HIV/AIDS Drug Access Initiatives in Côte D'ivoire, Senegal and Uganda: how access to antiretroviral treatment can become feasible in Africa. AIDS 2003 17 supplement 3 S1 S4 2-s2.0-0043130208 (Pubitemid 36951663)
80. Harrigan R., Measuring viral load in the clinical setting. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1995 10 1 S34 S40 2-s2.0-0029609080 (Pubitemid 26069644)
81. Fiscus S. A., Cheng B., Crowe S. M., Demeter L., Jennings C., Miller V., Respess R., Stevens W., HIV-1 viral load assays for resource-limited settings. PLoS Medicine 2006 3 10 e417 2-s2.0-39049176676
82. George E., Beauharnais C. A., Brignoli E., Noel F., Bois G., Rouzier P. D. M., Altenor M., Lauture D., Hosty M., Mehta S., Wright P. F., Pape J. W., Potential of a simplified p24 assay for early diagnosis of infant human immunodeficiency virus type 1 infection in Haiti. Journal of Clinical Microbiology 2007 45 10 3416 3418 2-s2.0-35348917642 10.1128/JCM.01314-07 (Pubitemid 47585675)